Literature DB >> 16298624

Pretransplant islet culture: a comparison of four serum-free media using a murine model of islet transplantation.

J Carter1, S Karmiol, M Nagy, R McElreath, C Calloway, A Motley, A Neill, H J Jang, A Posselt, P Stock.   

Abstract

INTRODUCTION: Human islet transplant protocols frequently incorporate a brief period of islet culture before transplantation. The optimal medium for pretransplant islet culture is unknown.
METHODS: We compared four serum-free media formulated for human islets: Miami (MM1), Memphis (M-SFM), Edmonton (EDM), and hCell OCZEM-SF/AF (hCell). Islets isolated from a single human pancreas with purity >80% were cultured in 2500-islet-equivalent (IE) fractions using the media listed. After 7 days, each 2500-IE fraction was grafted under the kidney capsule of a streptozocin-diabetic rag1 mouse (n = 4 per group). Mice were evaluated with serum glucose monitoring, stimulated C-peptide release, and glucose tolerance tests. Islet fractions transplanted immediately after isolation (n = 4 mice) served as controls. In vitro islet function was assessed on days 0 and 3 and included insulin release (after static glucose stimulation), total cellular C-peptide content, cell count, and viability.
RESULTS: Glucose control was improved in all cohorts of mice after transplant, but only islet grafts cultured in MM1 were statistically indistinguishable from fresh islets. MM1- and hCell-cultured islet grafts showed improved glucose tolerance compared with fresh islets; C-peptide release was similar among the four cohorts. In vitro, only islets cultured in MM1 had similar stimulation index to fresh islets, whereas only hCell- and MM1-cultured islets demonstrated recovery of C-peptide content and insulin release.
CONCLUSIONS: Media choice before transplant can influence islet quality, even when culture periods are short. Miami MM1 and hCell media may provide better islet protection than alternative media.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298624     DOI: 10.1016/j.transproceed.2005.09.073

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Glial cell line-derived neurotrophic factor enhances human islet posttransplantation survival.

Authors:  Simon M Mwangi; Yousef Usta; Nikrad Shahnavaz; Irene Joseph; Jose Avila; Jose Cano; Veerappa K Chetty; Christian P Larsen; Shanthi V Sitaraman; Shanthi Srinivasan
Journal:  Transplantation       Date:  2011-10-15       Impact factor: 4.939

2.  Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation.

Authors:  Cyrus Jahansouz; Cameron Jahansouz; Sean C Kumer; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.